ALPS Medical Breakthroughs ETF
SBIO
37 hedge funds and large institutions have $53M invested in ALPS Medical Breakthroughs ETF in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 6 closing their positions.
11% more capital invested
Capital invested by funds: $47.8M → $53M (+$5.13M)
6.03% more ownership
Funds ownership: 46.42% → 52.44% (+6%)
3% less funds holding
Funds holding: 38 → 37 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$6M |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$420K |
| 3 |
Jane Street
New York
|
+$357K |
| 4 |
GAM
Griffin Asset Management
New York
|
+$261K |
| 5 |
JIP
Jaffetilchin Investment Partners
Tampa,
Florida
|
+$245K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CVA
Central Valley Advisors
Sacramento,
California
|
-$536K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$496K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$370K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$241K |
| 5 |
VF
Virtu Financial
New York
|
-$221K |
SBIO Hedge Fund Activity: Q3 2024 in Review
37 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q3 2024, worth a combined $53M — up 11% from $47.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of SBIO and 5 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 9 added.
The largest buyer was International Assets Investment Management, opening a new position worth an estimated $6M. The largest seller was Central Valley Advisors, exiting entirely with an estimated $536K sold.
- 37 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q3 2024, down from 38 in Q2 2024.
- Funds reported $53M of ALPS Medical Breakthroughs ETF stock for Q3 2024, up 11% quarter-over-quarter.
- 5 funds opened new ALPS Medical Breakthroughs ETF positions in Q3 2024 and 6 closed out, a net change of -1 holder.
- The largest ALPS Medical Breakthroughs ETF buyer in Q3 2024 was International Assets Investment Management, an estimated $6M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q3 2024 was Central Valley Advisors, an estimated $536K sold.
Based on aggregated 13F filings for Q3 2024.